SCI Abstract

search
+
Bispecific T-cell engager therapy for multiple myeloma
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Cancer vaccines in hematologic malignancy: A systematic review of the rational and evidence for clinical use
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
CAR-T cell therapy for multiple myeloma: An update on the current state and future potential
All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Advancing MSC therapy: The next generation of potent mesenchymal stromal cells for systemic autoimmune rheumatic diseases
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Endogenous and exogenous cytokines: An overview and introduction
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Cytokines and immune effector cell therapy
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Cytokines in transplantation tolerance
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Immune reconstitution following allogeneic hematopoietic cell transplantation and CAR-T therapy: dynamics, determinants, and directions
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Applications and prospects of molecularly targeted drugs combined with CAR-T cell therapy to treat multiple myeloma
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
CAR-NK cells for haematological cancers
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Research progress of targeted BCMA CAR-T therapy for relapsed/refractory multiple myeloma antigen-negative relapse
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Tumor microenvironment in CAR-T cell therapy for lymphoma
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Natural born Killers: Harnessing NK cells to treat cancer
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Therapeutic initiatives using mesenchymal stem cells and other novel cells in hematology
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Precursor plasma cell disorders: Classification, risk stratification, and emerging role of early interception
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Corrigendum to “Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)” [Best Pract Res Clin Haematol 38 2 2025]
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Advances in NK cell therapy for multiple myeloma
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Adoptive cellular therapies in non-Hodgkin lymphomas
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Adoptive cellular therapies in multiple myeloma
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Immune therapy of haematological cancers
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 964f9...
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders
Myeloid neoplasms with germline predisposition have been recognized increasingly over the past decade with numerous newly ...
The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia
The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia
Improvements made during the last decades in the management of patients with hematologic neoplasia have resulted in increa...
Using real-world evidence in haematology
Using real-world evidence in haematology
Volume 37, Issue 1, March 2024, 101536Author links open overlay panel, , , , , , AbstractMost new drug approvals are based...
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS Registry
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS Registry
Allogeneic hematopoietic stem cell (HSC) transplantation is a curative therapy for many severe blood diseases. As many pat...
Corrigendum to “Designing and conducting a clinical trial in blood and marrow transplantation” [Best Pract Res Clin Haematol 36 (2023) 101471]
Corrigendum to “Designing and conducting a clinical trial in blood and marrow transplantation” [Best Pract Res Clin Haematol 36 (2023) 101471]
Volume 37, Issue 1, March 2024, 101538Author links open overlay panelMichael J. Martens a b, Yan Gao a, Aniko Szabo aShow ...
Corrigendum to “Endpoint selection and evaluation in hematology studies” [Best Pract Res Clin Haematol 36 (2023) 101479]
Corrigendum to “Endpoint selection and evaluation in hematology studies” [Best Pract Res Clin Haematol 36 (2023) 101479]
Volume 37, Issue 1, March 2024, 101540Author links open overlay panelRuta Brazauskas a, Mary Eapen b, Tao Wang aShow moreP...
Cytogenetics and genomics of acute myeloid leukemia
Cytogenetics and genomics of acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease with distinctive genetic abnormalities. The application of genetic...
Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors
Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors
Childhood and young adult survivors of Hodgkin lymphoma are at an elevated risk of developing breast cancer [[1], [2], [3]...
Load More
format_indent_increase